Sign in

CIK 0000730272

  • Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
042729386
Phone
+1 781-449-9560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. 4 Shares withheld for taxes Gebski Christine gave up 181 shares (to pay taxes)
  2. 4 Shares withheld for taxes Chief Operating Officer gave up 188 shares (to pay taxes)
  3. 4 Shares withheld for taxes Chief Operating Officer gave up 334 shares (to pay taxes)
  4. 4 Shares withheld for taxes Senior VP, R&D gave up 175 shares (to pay taxes)
  5. 4 Shares withheld for taxes Gebski Christine gave up 224 shares (to pay taxes)
  6. 4 Shares withheld for taxes Chief Financial Officer gave up 332 shares (to pay taxes)
  7. 4 Shares withheld for taxes Senior VP, R&D gave up 445 shares (to pay taxes)
  8. 4 Open-market sale Chief Executive Officer sold 17,355 shares at an average $276.85 ($4,804,674)
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 4 Insider Changes in Ownership
  18. 4 Insider Changes in Ownership
  19. 4 Insider Changes in Ownership
  20. 4 Insider Changes in Ownership

Page 11 of 34 · 669 filings